RJ Tesi

RJ Tesi

Company: Inmune Bio

Job title: Chief Executive & Medical Officer


Resistance to Immunotherapy Caused by MUC4 Expression in HER2+ Tumors – Bench to Bedside 12:00 pm

• Exploring how MUC4 expression predicts resistance to immunotherapy • Targeting soluble TNF reverses resistance in animal models • Understand how knowing the MUC4 status of a patient’s tumor will improve clinical decision making and should benefit patient outcomeRead more

day: Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.